Endo Pharmaceuticals Sues Matrix Laboratories and Mylan
August 18, 2011
Endo Pharmaceuticals filed suit against Matrix Laboratories and Mylan over three patents related to tetrahydrocarbazole derivatives for use in the treatment of migraines. 8/16, District of Delaware, 1:2011cv00717.
Access to the full article is currently available to RPX members only. Please contact us if you need further information.